Publications
Clark S, Marcum Z, Radich J, Bansal A. Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia. Journal of Oncology Pharmacy Practice. December 2021;27(8):1842-1852.
Ellison T, Clark S, Hong J, Frick K, Segev D. Potential Unintended Consequences of National Infectious Disease Screening Strategies in Deceased Donor Kidney Transplantation: A Cost-Effectiveness Analysis of Infectious Disease Screening Strategies. Applied Health Economics and Health Policy. 2020 Advance online publication.
Portnoy A, Clark S, Ozawa S, Jit M. The impact of vaccination on gender equity: conceptual framework and human papillomavirus (HPV) vaccine case study. Int J Equity Health. January 2020 14;19(1):10.
Lee BY, Brown S, Haidari L, Clark S, Abimbola T, Pallas S, Wallace A, Mitgang E, Leonard J, Bartsch S, MPH, Yemeke T, Zenkov E, Ozawa S. Economic Value of Vaccinating Geographically Hard-to-Reach Populations with Measles Vaccine: A Modeling Application in Kenya. Vaccine. April 2019;37(17):2377-2386.
Riumallo-Herl C, Chang A, Clark S, Constenla D, Clark A, Brenzel L, Verguet S. Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study. BMJ Global Health. April 2018; 3(2).
Chang A, Riumallo-Herl C, Perales N, Clark S, Clark A, Constenla D, Garske T, Jackson M, Jean K, Jit M, Jones E, Li X, Suraratdecha C, Bullock O, Johnson H, Brenzel L, Verguet S. The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries. Health Affairs. February 2018; 37(2):316-324.
Cohen A, Kulikowski C, Elbert T, Clark S, Constenla D, Sinha A. Decision Tree Model for Support of Health Policy Choices Based on Pneumococcal Conjugate Vaccine (PCV) Program Outcomes. Studies in Health Technology and Informatics. December 2017; 245: 40-44.
Ozawa S, Clark S, Portnoy A, Grewal S, Stack M, Sinha A, Mirelman A, Franklin H, Friberg I, Tam Y, Walker N, Clark A, Ferrari M, Suraratdecha C, Sweet S, Goldie S, Garskie T, Li M, Hansen P, Johnson H, Walker D. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020. Bulletin of the World Health Organization. September 2017; 95(9): 629-638.
Verma R, Clark S, Leider J, and Bishai D. Impact of state public health spending on incidence of mumps, pertussis, and rubella in the United States from 1980-2009. Health Services Research. February 2017; 52(1):176–190.
Haidari L, Brown S, Constenla D, Zenkov E, Ferguson M, de Broucker G, Ozawa S, Clark S, Portnoy A, Lee BY. Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique. Sexually Transmitted Diseases. February 2017; 44(4): 222-226.
Haidari L, Brown S, Constenla D, Zenkov E, Ferguson M, de Broucker G, Ozawa S, Clark S, Lee BY. The economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique. Vaccine. July 2016; 29(35):4161-5.
Ozawa S, Portnoy A, Getaneh H, Clark S, Knoll M, Bishai D, Yang H, Patwardhan P. Modeling the Economic Burden of Adult Vaccine Preventable Diseases (VPDs) in the United States. Health Affairs. November 2016; 35(11):2124-2132.
Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, and Walker D. Return on investment from childhood immunization in Low- And Middle-Income Countries, 2011–20. Health Affairs. February 2016; 35(2):199-207.
Constenla D and Clark S. Financing dengue vaccine introduction in the Americas: challenges and opportunities. Expert Rev Vaccines. January 2016; 15(4):547-59.
Melo M, Clark S, Barrio D. Miniaturization and globalization of clinical laboratory activities. Clin Chem Lab Med. April 2011; 49(4):581-6.